申请人:Kiuchi Masatoshi
公开号:US20090137530A1
公开(公告)日:2009-05-28
A novel amine compound represented by the following formula (I), which is superior in immunosuppressive action, rejection suppressive action and the like, and shows reduced side effects such as bradycardia and the like, or a pharmaceutically acceptable acid addition salt thereof, or hydrates thereof, or solvate, as well as a pharmaceutical composition containing this compound and a pharmaceutically acceptable carrier.
wherein R is a hydrogen atom or P(═O)(OH)
2
, X is an oxygen atom or a sulfur atom, Y is CH
2
CH
2
or CH═CH, R
1
is cyano or alkyl having a carbon number of 1 to 4 and substituted by a halogen atom(s), R
2
is alkyl having a carbon number of 1 to 4 and optionally substituted by a hydroxyl group(s) or a halogen atom(s), R
3
and R
4
may be the same or different and each is a hydrogen atom or alkyl having a carbon number of 1 to 4, and n is 5-8.
以下是该文的中文翻译:
一种新型胺类化合物,其化学式为(I),具有优异的免疫抑制作用、排斥抑制作用等,并显示出减少副作用,如心动过缓等。该化合物的药学可接受的酸盐、水合物或溶剂化物,以及包含该化合物和药学可接受的载体的制药组合物。其中,R为氢原子或P(═O)(OH)2,X为氧原子或硫原子,Y为CH2CH2或CH═CH,R1为氰基或碳数为1至4的烷基,并被卤素原子取代,R2为碳数为1至4的烷基,可选地被羟基或卤素原子取代,R3和R4可以相同也可以不同,每个为氢原子或碳数为1至4的烷基,n为5-8。